Optimal effectiveness of heart failure management — an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure

• Published in: Heart failure reviews Vol. 27; no. 5; pp. 1683 - 1748
• Main Authors: Hafkamp, Frederique J., Tio, Rene A., Otterspoor, Luuk C., de Greef, Tineke, van Steenbergen, Gijs J., van de Ven, Arjen R. T., Smits, Geert, Post, Hans, van Veghel, Dennis
• Format: Journal Article
• Language: English
• Published: New York Springer US 01-09-2022; Springer Nature B.V
• Subjects: Cardiology; Cell therapy; Congestive heart failure; Heart failure; Heart Failure - rehabilitation; Hospitalization; Humans; Medicine; Medicine & Public Health; Meta-analysis; Meta-Analysis as Topic; Mitral valve; Patients; Rehabilitation; Statins; Stroke Volume; Heart failure related hospitalizations; Medication; Interventions; Care pathways; Invasive therapy; Rehabilitations
• ISSN: 1382-4147; 1573-7322; 1573-7322
• DOI: 10.1007/s10741-021-10212-8

Heart failure (HF) is a major health concern, which accounts for 1–2% of all hospital admissions. Nevertheless, there remains a knowledge gap concerning which interventions contribute to effective prevention of HF (re)hospitalization. Therefore, this umbrella review aims to systematically review meta-analyses that examined the effectiveness of interventions in reducing HF-related (re)hospitalization in HFrEF patients. An electronic literature search was performed in PubMed, Web of Science, PsycInfo, Cochrane Reviews, CINAHL, and Medline to identify eligible studies published in the English language in the past 10 years. Primarily, to synthesize the meta-analyzed data, a best-evidence synthesis was used in which meta-analyses were classified based on level of validity. Secondarily, all unique RCTS were extracted from the meta-analyses and examined. A total of 44 meta-analyses were included which encompassed 186 unique RCTs. Strong or moderate evidence suggested that catheter ablation, cardiac resynchronization therapy, cardiac rehabilitation, telemonitoring, and RAAS inhibitors could reduce (re)hospitalization. Additionally, limited evidence suggested that multidisciplinary clinic or self-management promotion programs, beta-blockers, statins, and mitral valve therapy could reduce HF hospitalization. No, or conflicting evidence was found for the effects of cell therapy or anticoagulation. This umbrella review highlights different levels of evidence regarding the effectiveness of several interventions in reducing HF-related (re)hospitalization in HFrEF patients. It could guide future guideline development in optimizing care pathways for heart failure patients.